Akt is a serine-threonine kinase that has an important role in transducing survival signals. Akt also regulates a number of proteins involved in the apoptotic process. To find new Akt interactors, we performed a two-hybrid screening in yeast using full-length Akt cDNA as bait and a human cDNA heart library as prey. Among 200 clones obtained, two of them were identified as coding for the c-FLIP L protein. c-FLIP L is an endogenous inhibitor of death receptor-induced apoptosis through the caspase-8 pathway. Using co-immunoprecipitation experiments of either transfected or endogenous proteins, we confirmed the interaction between Akt and c-FLIP L . Furthermore, we observed that c-FLIP L overexpression interferes with Gsk3-b phosphorylation levels. Moreover, through its effects on Gsk3b, c-FLIP L overexpression in cancer cells induced resistance to tumor necrosis factorrelated apoptosis-inducing ligand (TRAIL). This effect was mediated by the regulation of p27
Apoptosis, or programmed cell death, is an evolutionarily conserved mechanism of elimination of unwanted cells. This endogenous death machinery is triggered via two principal signaling pathways. 1 The extrinsic pathway is activated by the engagement of death receptors on the cell surface. The binding of ligands, such as Fas, tumor necrosis factor (TNF), or TNF-related apoptosis-inducing ligand (TRAIL) to cognate death receptors (DRs) induces the formation of the deathinduced signaling complex (DISC). This DISC complex in turn recruits caspase-8 and promotes the cascade of procaspase activation. 2 The intrinsic pathway is triggered by various intracellular and extracellular stresses, signals of which converge mainly to the mitochondria. 2, 3 The balance between pro-and anti-apoptotic members of apoptosis is crucial for the regulation of survival and cell death. Aberrant resistance to apoptosis may lead to the development of cancer.
Cellular FLICE-inhibitory protein (c-FLIP) is a death effector domain (DED)-containing family member that inhibits one of the most proximal steps of DR-mediated apoptosis. Two isoforms of c-FLIP are commonly detected in human cells: a long form (c-FLIP L ) and a short form (c-FLIP S ). c-FLIP L , a 55-kDa protein, contains two DEDs and a caspase-like domain, whereas c-FLIP S , a 26-kDa protein consists only of two DEDs. 4 Both isoforms are recruited to the DISC, prevent procaspase-8 activation and block DR-mediated apoptosis, although through different mechanisms. 5, 6 c-FLIP L is overexpressed in a number of different tumors and its overexpression is related to TRAIL resistance. 7, 8 Beside cell death, c-FLIP L might also regulate other DR-mediated signals that may be important for tumor-promoting functions, such as proliferation, migration, inflammation or metastasis. [9] [10] [11] The activation of the transcription factor NF-kB, the PKB/Akt pathway and mitogen-activated protein kinases (MAPKs), such as c-Jun N-terminal kinase (JNK), extracellular signalregulated kinase (ERK) and p38, has been demonstrated to be a consequence of DR triggering. 9 Akt is a serine-threonine kinase that regulates the expression and the function of a number of proteins involved in the apoptotic process. 12 Akt interaction or phosphorylation of different signaling molecules may regulate their function by different mechanisms, including increased protein stability, cellular localization or binding to a different cellular partner. Akt interacts with a number of proteins involved in apoptotic signaling cascades, including BAD, 13 caspase-9, 14 the Forkhead transcription factor FOXO3 15 and Bcl-w. 16 The interaction of Akt with one of these proteins prevents apoptosis through several different mechanisms. 13 One major Akt substrate is the serinetheronine kinase Gsk3. 17 Originally studied for its role in glycogen metabolism and insulin action, Gsk3, present in the cells in two isoforms, Gsk3a and Gsk3b, has subsequently been shown to have central functions in many cellular processes, including transcription, cell cycle division, cell fate determination and stem cell maintenance, as well as in apoptosis. 17, 18 Gsk3 is constitutively active in resting cells, and is functionally inactivated after phosphorylation in response to different stimuli.
In this study, we set out to find and investigate new possible partners of Akt that may participate in the regulation of the apoptosis pathway. In this study, we provide evidence that Akt directly interacts with c-FLIP L . Furthermore, we demonstrate that c-FLIP L modulates the activation of Gsk3b. We also provide evidence that this interaction is important for the regulation of TRAIL sensitivity, through the regulation of p27 and caspase-3 levels.
Results
Akt interacts with c-FLIP L . To find new Akt interactors, we performed a yeast two-hybrid screening. We used the full-length human Akt cDNA sequence as bait and a human cDNA heart library as prey. Among the 200 clones obtained, two were identified to code for the anti-apoptotic protein, c-FLIP L . To prove the interaction between Akt and c-FLIP L , we performed immunoprecipitation experiments on endogenous proteins and on protein extracts from cells transfected with Akt and c-FLIP L cDNAs. We were able to confirm the Akt-c-FLIP L interaction in extracts from transfected cells (Figure 1a) , and in endogenous proteins from different cell lines (Figure 1b) immunoprecipitated using a monoclonal anti-Flag antibody and subsequently blotted using an anti-HA antibody. As shown in Figure 1a , c-FLIPL interacted at comparable levels with both the activated kinase and the kinase-dead Akt.
c-FLIP L is characterized by two death effector domains (DEDs), which are important for interaction with members of the apoptosis cascade. We examined whether these DED domains were important for the interaction with Akt. For this purpose, we generated three different mutants: cFLIP L I-DED, missing the first DED; cFLIP L II-DED, missing the second DED; and cFLIP DÀDED, missing both DEDs. The three mutants were transfected together with HA-Akt cDNA into HeLa cells. Extracts were immunoprecipitated using anti-Flag antibody and blotted with an anti-HA antibody. As shown in Figure 1c , all the c-FLIP L deletion mutants interacted with Akt, indicating that neither DED domain is necessary for the interaction with Akt.
We next investigated whether the carboxy terminal of c-FLIP L was the region of interaction with Akt. Role of c-FLIP modulation of Gsk3b pathway on TRAILinduced cell death. Although it has been clearly shown that c-FLIP L overexpression may cause resistance to TRAIL, the effects of Gsk3b on cell death are more controversial. 19 However, recently it was described that Gsk3b is involved in the resistance to TRAIL-induced apoptosis. Therefore, we investigated whether c-FLIP L -induced apoptosis resistance upon extrinsic pathway activation was at least in part mediated by its effects on Gsk3b activation.
For this purpose, HeLa cells were transfected with Flag c-FLIP L cDNAs alone or in the presence of lithium chloride, an inhibitor of Gsk3 activity. 20 The cells were subsequently incubated with TRAIL, and cell death was assessed using a cell viability assay or with propidium iodide staining followed by FACS analysis. As shown in Figure 3a and b, c-FLIPL overexpression decreased the sensitivity of HeLa to TRAILinduced apoptosis. However, treatment with LiCl completely counteracted the protective effect of c-FLIP on cell death (Figure 3a and b). To exclude unspecific effects of LiCl on cell death, the role of the Gsk3b pathway in the anti-apoptotic effect of c-FLIP was further evaluated using a specific Gsk3b kinase-inactive cDNA (Gsk3b-KI) and measuring caspase-8 activation. As shown in Figure 3c and d, c-FLIP L overexpression reduced TRAIL-induced caspase-8 activation, and this effect was counteracted by both LiCl and Gsk3b-KI cDNA. LiCl and Gsk3b-KI or GSk3b WT cDNA did not produce any effects on endogenous c-FLIP L levels (Supplementary Figure 1a) .
Effects of c-FLIP L on p27
Kip1 expression. Recently, Gsk3b inhibition has been suggested to regulate the cell cycle through regulation of p27 Kip1 levels. 21 In addition, we have recently shown that miRNAs regulate p27 Kip1 expression and TRAIL sensitivity. 22 Therefore, we addressed the question of whether the effect of c-FLIP L on TRAIL resistance was mediated through Gsk3b activity and thus on p27 expression levels.
As shown in Figure 4a , we observed that the levels of p27 Kip1 The downregulation of Gsk3b, by a specific siRNA or inactivation with LiCl, induced an increase in p27
Kip1 levels in HeLa Tween FLIP L compared to cells transfected with a scrambled siRNA (Figure 4d ). Taken together these results indicate that the effect of c-FLIP on p27
Kip1 is mediated by Gsk3b activity. We next investigated whether c-FLIP L -Gsk3 regulate p27
Kip1 at mRNA levels. To assess this point, HeLa cells were transfected with 5 mg of Flag c-FLIP L cDNA or a control vector for 48 h, and p27
Kip1 cDNA levels were evaluated by real-time PCR. Interestingly, we observed a significant reduction of p27
Kip1 mRNA levels in HeLa cells transfected with c-FLIP L but not with its mutant (Figure 4e ), suggesting that the c-FLIP L -Gsk3 pathway regulates p27 Kip1 expression levels through a transcriptional mechanism.
The effect of p27
Kip1 on TRAIL-mediated apoptotic signaling. We recently provided evidence that p27
Kip1 is involved in TRAIL resistance in non-small cell lung cancer (NSCLC). 22 We demonstrated that in TRAIL-resistant CALU-1 cells, miR-222 and miR-221 are overexpressed and target Gsk3-cFLIP pathway and TRAIL resistance C Quintavalle et al p27 Kip1 , inducing its downregulation. However, TRAILsensitive H460 cells exhibited reduced levels of miR-222 and miR-221 and increased p27
Kip1 expression. We therefore investigated whether p27
Kip1 modulated sensitivity to TRAIL-mediated cell death through the regulation of the apoptotic machinery molecules. To this aim, HeLa Tween FLIP cells, which express p27
Kip1 at very low levels, were transfected with HA-p27 cDNA, and caspase-3 levels were investigated by western blot analysis. We observed a significant increase in caspase-3 levels (Figure 5a ). Furthermore, silencing of p27
Kip1 using a specific siRNA in H460 cells, which express p27 Kip1 at high levels, resulted in reduction in caspase-3 level (Figure 5b) .
To further confirm the role of the FLIP-Gsk3 pathway on TRAIL apoptotic machinery, we evaluated caspase-3 levels in HeLa Tween c-FLIP-overexpressing cells, Gsk3 pathway of which was inhibited either by Gsk3 siRNA or by LiCl treatment. Both inhibitions resulted in an increase in caspase-3 expression levels, whereas no differences were observed in FADD levels ( Figure 5c ).
We investigated whether c-FLIP L modulated caspase-3 transcript levels through a transcriptional mechanism by 
Discussion
In this study, we provide evidence for a new role of c-FLIP L . c-FLIP L has been identified as an inhibitor of apoptosis triggered by the engagement of death receptors, such as Fas or TRAIL. 23, 24 c-FLIP L has also been implicated in other cellular functions, such as control of gene expression by ERK and NF-kB. 9, 25 We demonstrate, to the best of our knowledge, for the first time that Akt interacts with c-FLIP L , and that this interaction functionally regulates Gsk3b activation and apoptosis. Recently, Giampietri et al. 26 described that in c-FLIP transgenic mice, the phosphorylation of Akt and Gsk3b were reduced compared with control animals, even though caspase-3 activity was unchanged, highlighting an apoptosisindependent role of c-FLIP on pressure overload-mediated cardiac hypertrophy. The role of c-FLIP in heart development has been previously described in c-FLIP ko mice that, similar to FADD ko mice, developed severe defects of heart development. 27, 28 These studies identify c-FLIP as a new regulator of heart development and the hypertrophic response, possibly through Gsk3 signaling.
In this study, by genetic and biochemical methodologies, we have demonstrated that Akt is able to interact with c-FLIP L in the region stretching from a.a. 253 to a.a. 339 of the c-FLIP L protein. We observed that overexpression of c-FLIP L , although does not interfere with insulin-induced Akt activation, almost abolishes Gsk3b phosphorylation. The effects on Gsk3b were abrogated when we overexpressed c-FLIP L mutants that do not bind Akt. This may means that, by binding to Akt, c-FLIP L relegates the kinase in a different cellular compartment, and abolishes its ability to bind and phosphorylate its substrates. It is interesting that the phosphorylation of other Akt substrates besides Gsk3b, such as BAD, was reduced in c-FLIP L -overexpressing cells (data not shown).
It has been reported that Gsk3b contributes both to cell death and cell survival, depending on the cellular system and the appropriate stimuli. 19 Several studies indicated that inhibition of Gsk3b activity in cancer cells potentates apoptosis stimulated by death receptor. [29] [30] [31] [32] Furthermore, knocking out Gsk3b or inhibiting Gsk3b using lithium chloride, potentates TNF-induced apoptosis, indicating an anti-apoptotic role for Gsk3b. 30 Therefore, we asked whether c-FLIP L -mediated reduction of Gsk3b phosphorylation, and thus increase in its kinase activity, might be necessary for the anti-apoptotic function of c-FLIP L . Interestingly, when we interfered with Gsk3b activity, either using LiCl or with overexpression of a kinase-inactive form of Gsk3, anti-apoptotic c-FLIP L effects were significantly reduced. Thus, Gsk3b may act as an important mediator that participates in FLIP's anti-apoptotic function in human cancer.
We have recently demonstrated that p27 expression is linked to TRAIL resistance in NSCLC cells overexpressing miR-222. 22 We therefore investigated the level of p27 in different cells overexpressing c-FLIP L . Interestingly, we observed an inverse correlation between the c-FLIP L and Gsk3-cFLIP pathway and TRAIL resistance C Quintavalle et al p27 expression levels, as well as Gsk3b phosphorylation. This was also true in forced c-FLIP L -expressing cells (HEK-293 and HeLa). We then investigated whether c-FLIP could affect p27 levels through the activation of Gsk3b. For this purpose, we interfered with Gsk3b expression levels or activity in c-FLIP L -overexpressing cells and evaluated p27 levels. We observed that Gsk3b inhibition increased protein and mRNA levels of p27. The effects of FLIP L on p27 depend on its interaction with Akt, as c-FLIP L WT overexpression, but not its Akt-binding-site deletion mutants, was able to reduce p27 mRNA level. Recently, Wang et al. 21 described that Gsk3b negatively regulates p27 protein in MLL leukemia cells, thus being critical for the maintenance of MLL leukemia, and prospecting Gsk3 as an interesting target for this form of cancer. In the MLL cellular system, the effects were mainly at the protein level because the inhibition of Gsk3b did not affect mRNA levels. Therefore, although the final effect is similar, the functional relationships of Gsk3b with p27 seem to be cell type dependent. Gsk3b is a negative regulator of heart hypertrophy. 33 Interestingly, Hauck 34 recently described that silencing p27 induced cardiomyocyte hypertrophyc growth in the absence of growth-factor stimulation. It is interesting to speculate that Gsk3b mediates negative regulation of hypertrophyc growth through its effects on p27 expression levels.
Finally, we investigated the mechanisms of c-FLIP-Gsk3b -p27-mediated inhibition of cell death, by the evaluation of protein and mRNA levels of apoptosis-signaling molecules.
We showed that the absence of p27 induces a reduction in caspase-3 levels. This effect was mediated by Gsk3b because its inactivation induced an increase in caspase-3 level. The effect was specific on caspase-3 because other apoptosis-signaling molecules, such as FADD, were not affected. This effect occurred at the transcriptional level because c-FLIP L overexpression, but not its mutants, was able to reduce caspase-3 mRNA level, as assessed by RT-PCR. The overexpression of c-FLIP L also induces a significant reduction in the amount of the active caspase in untreated cells. Thus, taken together these data depict a model in which in c-FLIP-overexpressing cells, the activation of Gsk3b induces a reduction in p27
Kip1 and caspase-3 expression and activity levels, and thus a reduction in TRAILinduced cell death ( Figure 6) .
Recently, Gsk3b has been described as a protein complex associated with death receptors, DDX3, and cellular inhibitor of apoptosis protein-1 (cIAP-1). 29 In that study, Gsk3b inhibited apoptosis by interfering with DISC formation and caspase-8 activation. Our data reveal other possible mechanisms through which Gsk3 might inhibit apoptosis, that is, through regulation of p27 expression and that of downstream caspase-3 ( Figure 6 ).
Our data show that c-FLIP overexpression strongly reduces Akt-mediated Gsk3b phosphorylation. Furthermore, it's downregulation by a specific c-FLIP siRNA resulted in an increase in Gsk3b phosphorylation, as well as in p27 and caspase-3 levels.
In conclusion, this study demonstrates that anti-apoptotic functions of c-FLIP L are mediated by its effects on Gsk3b activity, and p27 and caspase-3 levels. These findings may be of importance in optimizing a strategy for the treatment of TRAIL-resistant human cancer.
Materials and Methods
Materials. Media, sera and antibiotics for cell culture were purchased from Life Technologies (Grand Island, NY, USA). Protein electrophoresis reagents were obtained from Bio-Rad (Richmond, VA, USA). Western blotting and ECL reagents were procured from GE Healthcare (Pixcataway, NJ, USA). All other chemicals were from Sigma (St. Louis, MO, USA). The antibodies: anti-caspase-8 antibody (1C12), anti-Akt, anti-P-Akt, anti-P-Gsk3b, anti-Gsk3b and anti-p27
Kip1 were purchased from Cell Signaling Technology (Danvers, MA, USA); anti-caspase-3 antibody was obtained from Abcam (Cambridge, MA, USA); anti-c-FLIP (NF6) antibody was purchased from Alexis (Lausen, Switzerland); anti-Flag M2 and anti-b-actin antibodies were obtained from Sigma; anti-HA antibody was obtained from Covance (Berkeley, CA, USA). SuperKiller TRAIL was purchased from Alexis.
Plasmids. The plasmids pcDNA3 Flag(hs)FLIP L and FLIP s were kindly provided by Professor Pasquale Vito and Henning Walczack, respectively. Akt WT, Akt E40K (constitutively active, HA-Akt D þ ) and Akt K179M (dominant-negative HA-Akt D) with an HA tag were a kind gift of Professor Gianluigi Condorelli. Gsk3b WT and Gsk3b kinase inactive (KI) cDNAs were kindly provided by Professor Junichi Sadoshima. p27 cDNA was kindly provided by Professor Alfredo Fusco. pRetroSuper vectors expressing RNAi for c-FLIP were obtained from Professor Simone Fulda.
Cell culture. Human HeLa, HEK-293, K562 and A459 cell lines were grown in DMEM containing 10% heat-inactivated FBS with 2 mM L-glutamine and 100 U/ml penicillin-streptomycin. DU145 and H460 cell lines were grown in RPMI containing 10% heat-inactivated FBS with 2 mM L-glutamine and 100 U/ml penicillinstreptomycin.
Yeast two-hybrid system. All experiments were performed in the yeast reporter MaV203. The human heart cDNA library was obtained from Invitrogen (Carlsbad, CA, USA). Screening of the library was performed essentially following instructions for the ProQuest two-hybrid system (Life Technologies) and has been previously described. 35 The GAL4 DNA-binding domain/human Akt fusion was obtained from Dr. Alfonso Bellacosa (Fox Chase Cancer Center, Philadelphia, PA, USA). Subsequently, yeast pLEx4-Akt plasmid was transformed with the pPC86AD cDNA library and plated onto plates lacking histidine in the presence of 3AT Figure 6 Role of cFLIP-Gsk3 signaling pathway in the regulation of cell death. In FLIP-overexpressing cells, activation of Gsk3b induces a reduction in p27
Kip1 and caspase-3 expression levels and a reduction in TRAIL-induced cell death Gsk3-cFLIP pathway and TRAIL resistance C Quintavalle et al (aminotriazole; 10 mM). Approximately 1.2 Â 10 6 individual clones were plated, and about 200 grew on the selective medium. Resistant colonies were grown on a master plate and then replica-plated onto selection plates to determine their ability to induce three independent reporters (HIS3, URA3 and lacZ). A total of 80 independent clones were isolated after this first screening. The DNA was isolated from each positive clone and sequenced to identify the inserts. Independent clones were retransformed into yeast and tested for interaction with a fresh Akt clone.
c-FLIP L deletion mutants generation. We generated three deletion mutants of c-FLIP L by PCR, using as template the plasmid pcDNA3-3 Â Flag-FLIP L . c-FLIP I-DED mutant, encoding a.a. 81-480, which lacks the first DED, was generated using the primers: Fw: 5 0 -cccaagcttacccacctgctcaggaaccct-3 0 and Rv: 5 0 -gctctagattatgtgtaggagaggata -3 0 ; c-FLIP-II-DED, encoding a.a. 1-93 and a.a. 178-480, which lacks the second DED, was generated using the primers Production of retroviral particles and infection of HeLa and HEK-293 cells. The c-FLIP L cDNA was cloned in PINCO vector. 36 The amphotropic packaging cell line Phoenix was transfected by standard calcium phosphate/ chloroquine method, and culture supernatants containing retroviral particles were collected at 48 h after transfection. Transduction was carried out by culturing (thrice) 5 Â 10 5 cells in 1 ml of 0.45-mmol/l filtered supernatant containing viral particles. Gene-transfer efficiency was evaluated by flow cytometry analysis based on the expression of the GFP reporter. The levels of c-FLIP expression were evaluated by immunoblot analysis using lysates of cells infected with the empty Tween vector (HeLa Tween and HEK-293 Tween) for comparison.
Western blotting. Total proteins from cells was extracted with RIPA buffer (0.15 mM NaCl, 0.05 mM Tris-HCl (pH 7.5), 1% Triton X-100, 0.1% SDS, 0.1% sodium deoxycolate and 1% Nonidet P40). A total of 50 mg of sample extract were resolved on 7.5-12% SDS-PAGE using a mini-gel apparatus (Bio-Rad Laboratories, Richmond, CA, USA) and transferred to Hybond-C extra nitrocellulose. Membranes were blocked for 1 h with 5% non-fat dry milk in TBS containing 0.05% Tween-20, incubated for 2 h with primary antibody, washed and incubated with secondary antibody, and visualized by chemiluminescence.
Phosphorylation experiments. HeLa cells were transiently transfected with different cDNAs as indicated. After 24 h, the cells were incubated in serum-free culture medium for 16 h at 371C. Insulin (final concentration, 100 nM) was then added, and the cells were rapidly rinsed with ice-cold saline followed by solubilization with 0.5 ml of RIPA buffer per dish for 1 h at 41C. Lysates were centrifuged at 5000 Â g for 20 min, and solubilized proteins were precipitated with the indicated antibodies, separated by SDS-PAGE, and revealed by western blot with antibodies recognizing the phosphorylated proteins.
Immunoprecipitation. Cells were cultured at a final concentration of 90% in p100 plates. The cells were collected with RIPA Buffer on a shaker for 30 min. A total of 1 mg of total extract was immunoprecipitated using the indicated antibodies (5 mg/ml anti-Flag, 2 mg/ml anti-HA, 3 mg/ml anti-Akt and 3 mg/ml antiGsk3b) for 16 h on shaker. Then, A/G beads (Santa Cruz Biotechnology, Santa Cruz, CA, USA) were added for 2 h. The beads were washed for three times with washing buffer (50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 0.1% Triton X-100, 10% glycerol), and then 20 ml of sample buffer was added; the samples were boiled at 1001C for 5 min and then the supernatants resolved by SDS-PAGE.
Caspase assay. The assay was performed using the Colorimetric CaspACE Assay System (Promega, Madison, WI, USA) as reported in the instruction manual. Briefly, HeLa cells were transfected with lipofectamine 2000; 48 h after transfection, cells were collected in caspase assay buffer and protein was quantified by Bradford Assay. A total of 50 mg of protein were used.
Cell death and cell proliferation quantification. Cells were plated in 96-well plates in triplicate and incubated at 371C in a 5%CO 2 incubator. To induce apoptosis, Superkiller TRAIL (Alexis) was used for 24 h at 500 ng/ml. Cell viability was evaluated with the CellTiter 96 AQ ueous One Solution Cell Proliferation Assay (Promega), according to the manufacturer's protocol. Metabolically active cells were detected by adding 20 ml of MTT to each well. After 30 min of incubation, the plates were analyzed in a Multilabel Counter (Bio-Rad, Richmond, VA, USA). Apoptosis was also assessed using annexin V-FITC Apoptosis Detection Kit followed by flow cytometric analysis. Cells were seeded at a density of 1.8 Â 10 6 cells per 100-mm dish, grown overnight in 10% FBS/RPMI, washed with PBS, and then treated for 24 h with 200 ng TRAIL. After incubation, cells were washed with cold PBS and removed from the plates using very mild trypsinization conditions (0.01 % trypsin/ EDTA). The resuspended cells were washed with cold PBS and stained with FITCconjugated annexin V antibody and propidium iodide (PI), according to the instructions provided by the manufacturer (Roche Applied Science, Indianapolis, IN, USA). Cells (50 000 per sample) were then subjected to flow cytometry analysis. Flow cytometry analysis and PI staining were performed as described previously. 16 To quantify caspase activation, cells were transfected with the indicated cDNA or treated with lithium chloride (20 mM) and then incubated with superkiller TRAIL for the indicated times. Lysates were examined by western blotting with anti-caspase-8 antibodies.
siRNA transfection. HeLa cells were cultured to 80% confluence, kept in antibiotic-free, serum-containing medium, and transiently transfected using Lipofectamine 2000 with 150 nmol anti-Gsk3-b siRNA (Invitrogen), a pool of two target-specific 20-25 nt siRNAs, or with siCONTROL oligonucleotides, as indicated. Cells were incubated with siRNAs for the indicated times.
The siRNAs were transfected with 6 ml transfection reagent, as described in the manufacturer's protocol. Anti p27
Kip1 siRNA was purchased from Santa Cruz Biotechnology. siCONTROL Non-Targeting siRNA Pool #2 (D-001206-14-05) was from obtained from Dhamarcon (Lafayette, CO, USA) and comprised four siCONTROL Non-Targeting siRNAs. Each individual siRNA within this pool was characterized by genome-wide microarray analysis and found to have minimal off-target signatures. 0 ) or scrambled oligonucleotide were cloned in the pRSC retroviral vector as described previously. 37 Cells were selected with 10 mg/ml puromycin.
